Weight loss in HCV patients can be used as a surrogate marker for evaluation of interferon [IFN-alpha] treatment efficacy - a prospective pilot study

Ibrar, Alam; Iftikhar, Alam; Ijaz, Ali; Muhammad, Ali

Ibrar, Alam; Iftikhar, Alam; Ijaz, Ali; Muhammad, Ali.

Pakistan Journal of Pharmaceutical Sciences. 2014; 27 (3): 571-576

in En | IMEMR | ID: emr-142176

Responsible library: EMRO

Subject(s)

Humans; Male; Hepacivirus; Weight Loss; Biomarkers; Interferon-alpha; Prospective Studies; Pilot Projects

Search on Google

Add to My VHL

XML

Index: IMEMR Main subject: Biomarkers / Weight Loss / Pilot Projects / Prospective Studies / Interferon-alpha / Hepacivirus Limits: Humans / Male Language: En Journal: Pak. J. Pharm. Sci. Year: 2014

Search on Google

Add to My VHL

XML